Basic Information
ID: ALA4032431
Type: ADME
Description: Drug level in 90% human serum treated with (4R,7S,10S,13S,16R)-16-((S)-2-((S)-2-amino-5-guanidinopentanamido)propanamido)-7,10-dibenzyl-13-(3-guanidinopropyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraazacycloheptadecane-4-carboxylic acid at 1 mM after 15 mins by ESI-RP-HPLC method
Format: BAO_0000366
Organism: Homo sapiens
Tissue: Serum
Target: Serum(ALA613426)
Document: ALA4028895
Drug level in 90% human serum treated with (4R,7S,10S,13S,16R)-16-((S)-2-((S)-2-amino-5-guanidinopentanamido)propanamido)-7,10-dibenzyl-13-(3-guanidinopropyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraazacycloheptadecane-4-carboxylic acid at 1 mM after 15 mins by ESI-RP-HPLC method: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4032431
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 743.91 | -1.01 | -1.01 |